| 53.75 0.56 (1.05%) | 07-26 16:00 | |||||||||||||
|
|
| Short term |   |
|||
| Mid term |   |
|||
| Targets | 6-month : | 63.66 | 1-year : | 74.35 |
| Resists | First : | 54.5 | Second : | 63.66 |
| Pivot price | 53 |
|||
| Supports | First : | 51.39 | Second : | 49.47 |
| MAs | MA(5) : | 53.54 |
MA(20) : | 52.66 |
| MA(100) : | 47.32 |
MA(250) : | 45.84 |
|
| MACD | MACD : | 0.9 |
Signal : | 0.9 |
| %K %D | K(14,3) : | 66 |
D(3) : | 71.3 |
| RSI | RSI(14): 67.6 |
|||
| 52-week | High : | 54.5 | Low : | 39.33 |
Price has closed above its short-term moving average. Short-term moving average is currently above mid-term; and above long-term moving average. From the relationship between price and moving averages: This stock is BULLISH in short-term; and BULLISH in mid-long term.[ VTR ] has closed below upper band by 17.7%. Bollinger Bands are 28.3% narrower than normal. The current width of the bands does not suggest anything about the future direction or movement of prices.
| If tomorrow: | Open lower | Open higher |
| High: | 54.01 - 54.33 | 54.33 - 54.64 |
| Low: | 52.32 - 52.7 | 52.7 - 53.07 |
| Close: | 53.16 - 53.73 | 53.73 - 54.27 |
Ventas, an S&P 500 company, operates at the intersection of two powerful and dynamic industries healthcare and real estate. As one of the world's foremost Real Estate Investment Trusts (REIT), we use the power of capital to unlock the value of real estate, partnering with leading care providers, developers, research and medical institutions, innovators and healthcare organizations whose success is buoyed by the demographic tailwind of an aging population. For more than twenty years, Ventas has followed a successful strategy that endures: combining a high-quality diversified portfolio of properties and capital sources to manage through cycles, working with industry leading partners, and a collaborative and experienced team focused on producing consistent growing cash flows and superior returns on a strong balance sheet, ultimately rewarding Ventas shareholders. As of September 30, 2020, Ventas owned or managed through unconsolidated joint ventures approximately 1,200 properties.
Fri, 26 Jul 2024
Natixis Sells 27,041 Shares of Ventas, Inc. (NYSE:VTR) - MarketBeat
Fri, 26 Jul 2024
What's in the Offing for Ventas (VTR) This Earnings Season? - Yahoo Finance
Thu, 25 Jul 2024
Ventas, Inc. (NYSE:VTR) Shares Sold by Blair William & Co. IL - Defense World
Wed, 24 Jul 2024
Ventas Inc. stock underperforms Wednesday when compared to competitors - MarketWatch
Wed, 24 Jul 2024
Ventas Inc. reaches 52-week high, hitting $54.245 - Investing.com
Tue, 23 Jul 2024
Ventas Inc. stock underperforms Tuesday when compared to competitors - MarketWatch
| Price to Book Value: P/BV, a ratio used to compare book value to its current market price, to gauge whether a stock is valued properly. |
Underperform |
| Price to Earnings: PE, the ratio for valuing a company that measures its current share price relative to its earnings per share (EPS). |
Underperform |
| Discounted cash flow: DCF, a valuation method used to estimate the value of an investment based on its expected future cash flows. |
Neutral |
| Return on Assets: ROA, indicates how profitable a company is in relation to its total assets, how efficiently uses assets to generate a profit. |
Underperform |
| Return on Equity: ROE, a measure of financial performance calculated by dividing net income by equity. a gauge of profitability and efficiency. |
Underperform |
| Debt to Equity: evaluate financial leverage, reflects the ability of equity to cover outstanding debts in the event of a business downturn. |
Underperform |
|
Exchange:
NYSE
|
|
|
Sector:
Real Estate
|
|
|
Industry:
REIT - Healthcare Facilities
|
|
| Shares Out | 405 (M) |
| Shares Float | 403 (M) |
| Held by Insiders | 0.6 (%) |
| Held by Institutions | 96.4 (%) |
| Shares Short | 7,610 (K) |
| Shares Short P.Month | 8,440 (K) |
| EPS | -0.16 |
| EPS Est Next Qtrly | 0 |
| EPS Est This Year | 0 |
| EPS Est Next Year | 0 |
| Book Value (p.s.) | 23.25 |
| Profit Margin | -1.6 % |
| Operating Margin | 12.3 % |
| Return on Assets (ttm) | 1.6 % |
| Return on Equity (ttm) | -0.7 % |
| Qtrly Rev. Growth | 10.6 % |
| Gross Profit (p.s.) | 0 |
| Sales Per Share | 11.38 |
| EBITDA (p.s.) | 4.44 |
| Qtrly Earnings Growth | 0 % |
| Operating Cash Flow | 1,140 (M) |
| Levered Free Cash Flow | 974 (M) |
| PE Ratio | -335.94 |
| PEG Ratio | -54.1 |
| Price to Book value | 2.31 |
| Price to Sales | 4.71 |
| Price to Cash Flow | 19.08 |
| Dividend | 0 |
| Forward Dividend | 0 |
| Dividend Yield | 0% |
| Dividend Pay Date | Invalid DateTime. |
| Ex-Dividend Date | Invalid DateTime. |
|
|
|
|
|
|
|
|
|